Beyond chemotherapy: proapoptotic and antiangiogenic drug effects in preclinical ovarian cancer models
PhD ceremony: Mr. A.R.M. van der Bilt, 14.30 uur, Academiegebouw, Broerstraat 5, Groningen
Dissertation: Beyond chemotherapy: proapoptotic and antiangiogenic drug effects in preclinical ovarian cancer models
Promotor(s): prof. E.G.E. de Vries, prof. A.G.J. van der Zee, prof. S. de Jong
Faculty: Medical Sciences
Standard therapy for ovarian cancer, consisting of platinum-based chemotherapy and surgical debulking, has been unchanged since its introduction over a decade ago. Other chemotherapeutic regimens did not improve the poor prognosis of advanced ovarian cancer patients. Alternative therapeutic strategies are therefore being pursued, by applying molecular targeted drugs. These drugs interfere with key biological processes relevant to ovarian cancer biology, amongst which are the potential of these cancers to evade programmed cell death (apoptosis) and to create a vascular supply (angiogenesis). In this thesis the effects of proapoptotic and anti-angiogenic targeted drugs was investigated in preclinical ovarian cancer models.
Last modified: | 13 March 2020 12.01 a.m. |
More news
-
16 April 2024
UG signs Barcelona Declaration on Open Research Information
In a significant stride toward advancing responsible research assessment and open science, the University of Groningen has officially signed the Barcelona Declaration on Open Research Information.
-
02 April 2024
Flying on wood dust
Every two weeks, UG Makers puts the spotlight on a researcher who has created something tangible, ranging from homemade measuring equipment for academic research to small or larger products that can change our daily lives. That is how UG...
-
27 March 2024
UG/UMCG researchers receive prestigious research grant
RUG/UMCG scientists Mark Hipp, Bart Eggen, Moniek Tromp and Marleen Kamperman, along with colleagues, are involved in four of seven Dutch science consortia.